The COVID-19 pandemic is now approaching 2 years old, with more than 440 million people
infected and nearly six million dead worldwide, making it the most significant pandemic …

Cytomegalovirus (CMV) is the most common cause of congenital infections in developed
countries because is capable of infecting the fetus after both primary and recurrent maternal …

The respiratory system, especially the lung, is the key site of pathological injury induced by
SARS-CoV-2 infection. Given the low feasibility of targeted delivery of antibodies into the …

The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of
abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

In late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus
emerged in China and quickly spread into a worldwide pandemic. It has caused millions of …

Historically, passive immunotherapy is an approved approach for protecting and treating
humans against various diseases when other alternative therapeutic options are …

Neonates, especially preterm neonates, have the highest risk of sepsis of all age groups.
Transient immaturity of the neonatal immune system is an important risk factor. Neonates …

Avoiding physical contact is regarded as one of the safest and most advisable strategies to
follow to reduce pathogen spread. The flip side of this approach is that a lack of social …

Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No
approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics …

Monoclonal antibodies (mAbs) are an attractive therapeutic platform for the prevention and
treatment of influenza virus infection. There are two major glycoproteins on the influenza …